Jenscare Scientific Co Ltd
Company Profile
Business description
Jenscare Scientific Co Ltd is engaged in the manufacturing, research, and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. Geographically, the company generates the majority of its revenue from the Chinese mainland.
Contact
No. 777 Binhai 4th Road
Block 5, B Area, Hangzhou Bay New Area
Zhejiang Province
Ningbo
CHNT: +86 57463935666
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
195
Stocks News & Analysis
stocks
Australia’s oldest REIT undervalued
stocks
Stop asking if there’s a stock market bubble. Ask this instead.
stocks
Are negative AI narratives holding this ASX share back?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,920.20 | 1.50 | -0.02% |
| CAC 40 | 8,337.29 | 66.70 | -0.79% |
| DAX 40 | 25,040.28 | 44.47 | 0.18% |
| Dow JONES (US) | 52,305.24 | 13.96 | -0.03% |
| FTSE 100 | 10,478.34 | 18.78 | -0.18% |
| HKSE | 22,881.02 | 145.66 | -0.63% |
| NASDAQ | 26,040.03 | 173.69 | -0.66% |
| Nikkei 225 | 69,342.03 | 1,132.93 | -1.61% |
| NZX 50 Index | 13,555.35 | 55.15 | -0.41% |
| S&P 500 | 7,483.23 | 16.13 | -0.22% |
| S&P/ASX 200 | 8,716.60 | 6.00 | 0.07% |
| SSE Composite Index | 4,112.11 | 0.34 | -0.01% |